Review



primary anti siglec1 antibody  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Proteintech primary anti siglec1 antibody
    Fig. 6 Protein–protein interaction network and univariate COX. A Gene networks from the module gene based on the WGCNA method. B Univariate Cox regression analysis, listing to prognosis. C, D Overall survival analysis of the CYHR1 and <t>SIGLEC1</t> genes in colon cancer based on the Kaplan–Meier plotter
    Primary Anti Siglec1 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary anti siglec1 antibody/product/Proteintech
    Average 94 stars, based on 7 article reviews
    primary anti siglec1 antibody - by Bioz Stars, 2026-04
    94/100 stars

    Images

    1) Product Images from "SIGLEC1 has the potential to be an immune-related prognostic indicator in colon adenocarcinoma: a study based on transcriptomic data and Mendelian randomization analysis."

    Article Title: SIGLEC1 has the potential to be an immune-related prognostic indicator in colon adenocarcinoma: a study based on transcriptomic data and Mendelian randomization analysis.

    Journal: Discover oncology

    doi: 10.1007/s12672-025-02093-2

    Fig. 6 Protein–protein interaction network and univariate COX. A Gene networks from the module gene based on the WGCNA method. B Univariate Cox regression analysis, listing to prognosis. C, D Overall survival analysis of the CYHR1 and SIGLEC1 genes in colon cancer based on the Kaplan–Meier plotter
    Figure Legend Snippet: Fig. 6 Protein–protein interaction network and univariate COX. A Gene networks from the module gene based on the WGCNA method. B Univariate Cox regression analysis, listing to prognosis. C, D Overall survival analysis of the CYHR1 and SIGLEC1 genes in colon cancer based on the Kaplan–Meier plotter

    Techniques Used:

    Fig. 7 GSEA delineates high SIGLEC1 expression and low expression. A HALLMARK collection enriched in the high SIGLEC1 expression sam- ple. B HALLMARK collection enriched in the low SIGLEC1 expression sample. C Enriched immunologic gene sets in C7 collection of the high SIGLEC1 expression group. D Enriched immunologic gene sets in C7 collection of the low SIGLEC1 expression group
    Figure Legend Snippet: Fig. 7 GSEA delineates high SIGLEC1 expression and low expression. A HALLMARK collection enriched in the high SIGLEC1 expression sam- ple. B HALLMARK collection enriched in the low SIGLEC1 expression sample. C Enriched immunologic gene sets in C7 collection of the high SIGLEC1 expression group. D Enriched immunologic gene sets in C7 collection of the low SIGLEC1 expression group

    Techniques Used: Expressing

    Fig. 9 Significant correlation between the expression of SIGLEC1 and the proportion of tumor-infiltrating immune cells. A Scatter plot showing the correlation between 10 types of tumor-infiltrating immune cell ratio with the SIGLEC1 expression (all p < 0.05). B Mendelian randomization analysis. C Correlation between the immune checkpoint genes between SIGLEC1 expression
    Figure Legend Snippet: Fig. 9 Significant correlation between the expression of SIGLEC1 and the proportion of tumor-infiltrating immune cells. A Scatter plot showing the correlation between 10 types of tumor-infiltrating immune cell ratio with the SIGLEC1 expression (all p < 0.05). B Mendelian randomization analysis. C Correlation between the immune checkpoint genes between SIGLEC1 expression

    Techniques Used: Expressing

    Fig. 10 Clinical COAD samples validate SIGLEC1 signature. A The immunohistochemical (IHC) staining on clinical sample tissue microarrays indicates high and low expression of SIGLEC1. B Kaplan–Meier analysis of SIGLEC1 expression levels
    Figure Legend Snippet: Fig. 10 Clinical COAD samples validate SIGLEC1 signature. A The immunohistochemical (IHC) staining on clinical sample tissue microarrays indicates high and low expression of SIGLEC1. B Kaplan–Meier analysis of SIGLEC1 expression levels

    Techniques Used: Immunohistochemical staining, Immunohistochemistry, Expressing



    Similar Products

    primary anti siglec1 antibody  (Proteintech)
    94
    Proteintech primary anti siglec1 antibody
    Fig. 6 Protein–protein interaction network and univariate COX. A Gene networks from the module gene based on the WGCNA method. B Univariate Cox regression analysis, listing to prognosis. C, D Overall survival analysis of the CYHR1 and <t>SIGLEC1</t> genes in colon cancer based on the Kaplan–Meier plotter
    Primary Anti Siglec1 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary anti siglec1 antibody/product/Proteintech
    Average 94 stars, based on 1 article reviews
    primary anti siglec1 antibody - by Bioz Stars, 2026-04
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Fig. 6 Protein–protein interaction network and univariate COX. A Gene networks from the module gene based on the WGCNA method. B Univariate Cox regression analysis, listing to prognosis. C, D Overall survival analysis of the CYHR1 and SIGLEC1 genes in colon cancer based on the Kaplan–Meier plotter

    Journal: Discover oncology

    Article Title: SIGLEC1 has the potential to be an immune-related prognostic indicator in colon adenocarcinoma: a study based on transcriptomic data and Mendelian randomization analysis.

    doi: 10.1007/s12672-025-02093-2

    Figure Lengend Snippet: Fig. 6 Protein–protein interaction network and univariate COX. A Gene networks from the module gene based on the WGCNA method. B Univariate Cox regression analysis, listing to prognosis. C, D Overall survival analysis of the CYHR1 and SIGLEC1 genes in colon cancer based on the Kaplan–Meier plotter

    Article Snippet: Immunohistochemical staining was conducted using primary anti-SIGLEC1 antibody (1:200; 55427-1- AP, proteintech, China).

    Techniques:

    Fig. 7 GSEA delineates high SIGLEC1 expression and low expression. A HALLMARK collection enriched in the high SIGLEC1 expression sam- ple. B HALLMARK collection enriched in the low SIGLEC1 expression sample. C Enriched immunologic gene sets in C7 collection of the high SIGLEC1 expression group. D Enriched immunologic gene sets in C7 collection of the low SIGLEC1 expression group

    Journal: Discover oncology

    Article Title: SIGLEC1 has the potential to be an immune-related prognostic indicator in colon adenocarcinoma: a study based on transcriptomic data and Mendelian randomization analysis.

    doi: 10.1007/s12672-025-02093-2

    Figure Lengend Snippet: Fig. 7 GSEA delineates high SIGLEC1 expression and low expression. A HALLMARK collection enriched in the high SIGLEC1 expression sam- ple. B HALLMARK collection enriched in the low SIGLEC1 expression sample. C Enriched immunologic gene sets in C7 collection of the high SIGLEC1 expression group. D Enriched immunologic gene sets in C7 collection of the low SIGLEC1 expression group

    Article Snippet: Immunohistochemical staining was conducted using primary anti-SIGLEC1 antibody (1:200; 55427-1- AP, proteintech, China).

    Techniques: Expressing

    Fig. 9 Significant correlation between the expression of SIGLEC1 and the proportion of tumor-infiltrating immune cells. A Scatter plot showing the correlation between 10 types of tumor-infiltrating immune cell ratio with the SIGLEC1 expression (all p < 0.05). B Mendelian randomization analysis. C Correlation between the immune checkpoint genes between SIGLEC1 expression

    Journal: Discover oncology

    Article Title: SIGLEC1 has the potential to be an immune-related prognostic indicator in colon adenocarcinoma: a study based on transcriptomic data and Mendelian randomization analysis.

    doi: 10.1007/s12672-025-02093-2

    Figure Lengend Snippet: Fig. 9 Significant correlation between the expression of SIGLEC1 and the proportion of tumor-infiltrating immune cells. A Scatter plot showing the correlation between 10 types of tumor-infiltrating immune cell ratio with the SIGLEC1 expression (all p < 0.05). B Mendelian randomization analysis. C Correlation between the immune checkpoint genes between SIGLEC1 expression

    Article Snippet: Immunohistochemical staining was conducted using primary anti-SIGLEC1 antibody (1:200; 55427-1- AP, proteintech, China).

    Techniques: Expressing

    Fig. 10 Clinical COAD samples validate SIGLEC1 signature. A The immunohistochemical (IHC) staining on clinical sample tissue microarrays indicates high and low expression of SIGLEC1. B Kaplan–Meier analysis of SIGLEC1 expression levels

    Journal: Discover oncology

    Article Title: SIGLEC1 has the potential to be an immune-related prognostic indicator in colon adenocarcinoma: a study based on transcriptomic data and Mendelian randomization analysis.

    doi: 10.1007/s12672-025-02093-2

    Figure Lengend Snippet: Fig. 10 Clinical COAD samples validate SIGLEC1 signature. A The immunohistochemical (IHC) staining on clinical sample tissue microarrays indicates high and low expression of SIGLEC1. B Kaplan–Meier analysis of SIGLEC1 expression levels

    Article Snippet: Immunohistochemical staining was conducted using primary anti-SIGLEC1 antibody (1:200; 55427-1- AP, proteintech, China).

    Techniques: Immunohistochemical staining, Immunohistochemistry, Expressing